cd38 inhibitor and 5-amino-1mq synergy nad+ Emerging chemical strategies for inhibition: restoring metabolism disease control A Potent and Specific CD38
A Potent and Specific CD38 Inhibitor Ameliorates Age Related Metabolic Dysfunction by Reversing Tissue NAD+ Decline: Cell Metabolism The Pharmacology of CD38 NADase: An emerging target for cancer and aging diseases PMC Evolving roles of CD38 metabolism in solid tumour microenvironment British Journal of Cancer Heavy chain antibody targeting of CD38 NAD+ hydrolase ectoenzyme to prevent fibrosis in multiple organs Scientific Reports CD38 as theranostic target in oncology Journal of Translational Medicine Springer Nature Link Small Molecule CD38 Inhibitors: Synthesis of 8 Amino N1 inosine 5 monophosphate, Analogues and Early Structure Activity Relationship
Pay in 4 interest-free payments of $5.19 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12





